-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Vera Therapeutics, Raises Price Target to $66

Benzinga·12/19/2025 17:52:26
語音播報
B of A Securities analyst Dina Ramadane maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $48 to $66.